These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 12406885)
1. Identification of an MIP-1alpha -binding heparan sulfate oligosaccharide that supports long-term in vitro maintenance of human LTC-ICs. Stringer SE; Nelson MS; Gupta P Blood; 2003 Mar; 101(6):2243-5. PubMed ID: 12406885 [TBL] [Abstract][Full Text] [Related]
2. Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates: requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteins. Gupta P; Oegema TR; Brazil JJ; Dudek AZ; Slungaard A; Verfaillie CM Blood; 2000 Jan; 95(1):147-55. PubMed ID: 10607697 [TBL] [Abstract][Full Text] [Related]
3. Stromal fibroblast heparan sulfate is required for cytokine-mediated ex vivo maintenance of human long-term culture-initiating cells. Gupta P; McCarthy JB; Verfaillie CM Blood; 1996 Apr; 87(8):3229-36. PubMed ID: 8605338 [TBL] [Abstract][Full Text] [Related]
4. Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche. Gupta P; Oegema TR; Brazil JJ; Dudek AZ; Slungaard A; Verfaillie CM Blood; 1998 Dec; 92(12):4641-51. PubMed ID: 9845530 [TBL] [Abstract][Full Text] [Related]
5. Ex vivo culture of CD34+/Lin-/DR- cells in stroma-derived soluble factors, interleukin-3, and macrophage inflammatory protein-1alpha maintains not only myeloid but also lymphoid progenitors in a novel switch culture assay. Miller JS; McCullar V; Verfaillie CM Blood; 1998 Jun; 91(12):4516-22. PubMed ID: 9616147 [TBL] [Abstract][Full Text] [Related]
6. NOD/SCID repopulating cells but not LTC-IC are enriched in human CD34+ cells expressing the CCR1 chemokine receptor. de Wynter EA; Heyworth CM; Mukaida N; Matsushima K; Testa NG Leukemia; 2001 Jul; 15(7):1092-101. PubMed ID: 11455979 [TBL] [Abstract][Full Text] [Related]
7. A clinically suitable ex vivo expansion culture system for LTC-IC and CFC using stroma-conditioned medium. Bhatia R; McGlave PB; Miller JS; Wissink S; Lin WN; Verfaillie CM Exp Hematol; 1997 Aug; 25(9):980-91. PubMed ID: 9257812 [TBL] [Abstract][Full Text] [Related]
8. Stromal factors support the expansion of the whole hemopoietic spectrum from bone marrow CD34+DR- cells and of some hemopoietic subsets from CD34+ and CD34+DR+ cells. Herman P; Ferrant A; De Bruyère M; Straetmans N Leukemia; 1998 May; 12(5):735-45. PubMed ID: 9593272 [TBL] [Abstract][Full Text] [Related]
9. The type of stromal feeder used in limiting dilution assays influences frequency and maintenance assessment of human long-term culture initiating cells. Punzel M; Moore KA; Lemischka IR; Verfaillie CM Leukemia; 1999 Jan; 13(1):92-7. PubMed ID: 10049066 [TBL] [Abstract][Full Text] [Related]
10. Phenotypic and functional characterization of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver. Roy V; Miller JS; Verfaillie CM Exp Hematol; 1997 May; 25(5):387-94. PubMed ID: 9168060 [TBL] [Abstract][Full Text] [Related]
11. Pre-treatment of peripheral blood progenitor cells with macrophage inflammatory protein-1alpha induces prolonged survival of early progenitor cells over 6 weeks of long-term culture. Egger D; Günther C; Helbig W; Schulze E Br J Haematol; 1998 Dec; 103(4):1181-3. PubMed ID: 9886339 [TBL] [Abstract][Full Text] [Related]
12. Differentiation stage-specific regulation of primitive human hematopoietic progenitor cycling by exogenous and endogenous inhibitors in an in vivo model. Cashman JD; Clark-Lewis I; Eaves AC; Eaves CJ Blood; 1999 Dec; 94(11):3722-9. PubMed ID: 10572085 [TBL] [Abstract][Full Text] [Related]
13. Macrophage inflammatory protein 1 alpha, interleukin 3 and diffusible marrow stromal factors maintain human hematopoietic stem cells for at least eight weeks in vitro. Verfaillie CM; Catanzarro PM; Li WN J Exp Med; 1994 Feb; 179(2):643-9. PubMed ID: 8294873 [TBL] [Abstract][Full Text] [Related]
14. Macrophage inflammatory protein 1alpha enhances in a different manner adhesion of hematopoietic progenitor cells from bone marrow, cord blood, and mobilized peripheral blood. Suehiro Y; Muta K; Umemura T; Abe Y; Nishimura J; Nawata H Exp Hematol; 1999 Nov; 27(11):1637-45. PubMed ID: 10560911 [TBL] [Abstract][Full Text] [Related]
15. Macrophage-inflammatory protein-1alpha receptor expression on normal and chronic myeloid leukemia CD34+ cells. Nicholls SE; Lucas G; Graham GJ; Russell NH; Mottram R; Whetton AD; Buckle AM J Immunol; 1999 May; 162(10):6191-9. PubMed ID: 10229864 [TBL] [Abstract][Full Text] [Related]
16. The limited infectability by R5 HIV of CD34(+) cells from thymus, cord, and peripheral blood and bone marrow is explained by their ability to produce beta-chemokines. Majka M; Rozmyslowicz T; Ratajczak J; Dobrowsky A; Pietrzkowski Z; Gaulton GN; Janowska-Wieczorek A; Ratajczak MZ Exp Hematol; 2000 Dec; 28(12):1334-42. PubMed ID: 11146155 [TBL] [Abstract][Full Text] [Related]
17. Direct contact between CD34+lin- cells and stroma induces a soluble activity that specifically increases primitive hematopoietic cell production. Koller MR; Oxender M; Jensen TC; Goltry KL; Smith AK Exp Hematol; 1999 Apr; 27(4):734-41. PubMed ID: 10210331 [TBL] [Abstract][Full Text] [Related]
18. Factor(s) secreted by AFT024 fetal liver cells following stimulation with human cytokines are important for human LTC-IC growth. Punzel M; Gupta P; Roodell M; Mortari F; Verfaillie CM Leukemia; 1999 Jul; 13(7):1079-84. PubMed ID: 10400424 [TBL] [Abstract][Full Text] [Related]
19. Differential response of CD34+ cells isolated from cord blood and bone marrow to MIP-1 alpha and the expression of MIP-1 alpha receptors on these immature cells. de Wynter EA; Durig J; Cross MA; Heyworth CM; Testa NG Stem Cells; 1998; 16(5):349-56. PubMed ID: 9766815 [TBL] [Abstract][Full Text] [Related]